Viemed Healthcare (NASDAQ:VMD – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other research firms have also weighed in on VMD. Weiss Ratings raised shares of Viemed Healthcare […]

Wall Street Zen lowered shares of LB Pharmaceuticals (NASDAQ:LBRX – Free Report) from a hold rating to a sell rating in a report released on Saturday morning. Other equities research analysts have also issued research reports about the company. Roth Capital reaffirmed a “buy” rating and issued a $37.00 target price on shares of LB […]

Wall Street Zen cut shares of Avalyn Pharma (NASDAQ:AVLN – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday morning. A number of other equities analysts have also recently commented on the stock. Morgan Stanley lifted their price target on shares of Avalyn Pharma from […]

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday. Several other analysts also recently issued reports on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of […]